nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—DRD3—attention deficit hyperactivity disorder	0.358	0.449	CbGaD
Amisulpride—DRD2—attention deficit hyperactivity disorder	0.248	0.311	CbGaD
Amisulpride—HTR2A—attention deficit hyperactivity disorder	0.192	0.24	CbGaD
Amisulpride—HTR7—locus ceruleus—attention deficit hyperactivity disorder	0.0113	0.212	CbGeAlD
Amisulpride—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00708	0.132	CbGeAlD
Amisulpride—HTR7—autonomic nervous system—attention deficit hyperactivity disorder	0.00603	0.113	CbGeAlD
Amisulpride—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00376	0.0704	CbGeAlD
Amisulpride—DRD3—nervous system—attention deficit hyperactivity disorder	0.0017	0.0319	CbGeAlD
Amisulpride—DRD3—central nervous system—attention deficit hyperactivity disorder	0.00164	0.0307	CbGeAlD
Amisulpride—HTR2B—forebrain—attention deficit hyperactivity disorder	0.00164	0.0307	CbGeAlD
Amisulpride—Alizapride—DRD2—attention deficit hyperactivity disorder	0.00153	0.199	CrCbGaD
Amisulpride—HTR7—forebrain—attention deficit hyperactivity disorder	0.0014	0.0263	CbGeAlD
Amisulpride—HTR2B—cardiovascular system—attention deficit hyperactivity disorder	0.00139	0.026	CbGeAlD
Amisulpride—DRD2—forebrain—attention deficit hyperactivity disorder	0.00133	0.0249	CbGeAlD
Amisulpride—DRD3—brain—attention deficit hyperactivity disorder	0.0013	0.0244	CbGeAlD
Amisulpride—Remoxipride—DRD4—attention deficit hyperactivity disorder	0.00125	0.163	CrCbGaD
Amisulpride—HTR7—cardiovascular system—attention deficit hyperactivity disorder	0.00119	0.0222	CbGeAlD
Amisulpride—Remoxipride—DRD3—attention deficit hyperactivity disorder	0.00108	0.141	CrCbGaD
Amisulpride—HTR7—midbrain—attention deficit hyperactivity disorder	0.000928	0.0174	CbGeAlD
Amisulpride—Sulpiride—DRD3—attention deficit hyperactivity disorder	0.000903	0.118	CrCbGaD
Amisulpride—HTR2B—nervous system—attention deficit hyperactivity disorder	0.000891	0.0167	CbGeAlD
Amisulpride—DRD2—midbrain—attention deficit hyperactivity disorder	0.000877	0.0164	CbGeAlD
Amisulpride—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000876	0.0164	CbGeAlD
Amisulpride—HTR2B—central nervous system—attention deficit hyperactivity disorder	0.000858	0.0161	CbGeAlD
Amisulpride—HTR7—nervous system—attention deficit hyperactivity disorder	0.000763	0.0143	CbGeAlD
Amisulpride—Remoxipride—DRD2—attention deficit hyperactivity disorder	0.000746	0.0973	CrCbGaD
Amisulpride—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000741	0.0139	CbGeAlD
Amisulpride—HTR7—central nervous system—attention deficit hyperactivity disorder	0.000734	0.0137	CbGeAlD
Amisulpride—DRD2—nervous system—attention deficit hyperactivity disorder	0.000721	0.0135	CbGeAlD
Amisulpride—HTR7—cerebellum—attention deficit hyperactivity disorder	0.000718	0.0134	CbGeAlD
Amisulpride—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000694	0.013	CbGeAlD
Amisulpride—HTR2B—brain—attention deficit hyperactivity disorder	0.000681	0.0127	CbGeAlD
Amisulpride—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000679	0.0127	CbGeAlD
Amisulpride—Sulpiride—DRD2—attention deficit hyperactivity disorder	0.000625	0.0816	CrCbGaD
Amisulpride—HTR7—brain—attention deficit hyperactivity disorder	0.000583	0.0109	CbGeAlD
Amisulpride—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000579	0.0108	CbGeAlD
Amisulpride—Remoxipride—HTR2A—attention deficit hyperactivity disorder	0.000576	0.0752	CrCbGaD
Amisulpride—Metoclopramide—DRD3—attention deficit hyperactivity disorder	0.000566	0.0739	CrCbGaD
Amisulpride—DRD2—brain—attention deficit hyperactivity disorder	0.000551	0.0103	CbGeAlD
Amisulpride—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000476	0.0089	CbGeAlD
Amisulpride—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000458	0.00857	CbGeAlD
Amisulpride—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000448	0.00838	CbGeAlD
Amisulpride—Metoclopramide—DRD2—attention deficit hyperactivity disorder	0.000392	0.0511	CrCbGaD
Amisulpride—HTR2A—brain—attention deficit hyperactivity disorder	0.000364	0.0068	CbGeAlD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000119	0.000845	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000118	0.000842	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000118	0.000836	CbGpPWpGaD
Amisulpride—HTR2B—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000117	0.000832	CbGpPWpGaD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000116	0.000827	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000113	0.000805	CbGpPWpGaD
Amisulpride—DRD2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000113	0.000803	CbGpPWpGaD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000112	0.000798	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000112	0.000796	CbGpPWpGaD
Amisulpride—HTR2A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.000111	0.00079	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000111	0.000787	CbGpPWpGaD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000111	0.000787	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000111	0.000786	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00011	0.000783	CbGpPWpGaD
Amisulpride—DRD2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00011	0.000779	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.000109	0.000775	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000108	0.000767	CbGpPWpGaD
Amisulpride—DRD2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000108	0.000766	CbGpPWpGaD
Amisulpride—DRD2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000106	0.000757	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000106	0.000751	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000105	0.000749	CbGpPWpGaD
Amisulpride—DRD2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000105	0.000747	CbGpPWpGaD
Amisulpride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000105	0.000744	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000105	0.000744	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000104	0.000736	CbGpPWpGaD
Amisulpride—HTR2A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000103	0.000735	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000103	0.000732	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000103	0.000732	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000102	0.000725	CbGpPWpGaD
Amisulpride—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000102	0.000723	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.0001	0.000713	CbGpPWpGaD
Amisulpride—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.0001	0.000712	CbGpPWpGaD
Amisulpride—DRD2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.0001	0.000711	CbGpPWpGaD
Amisulpride—HTR7—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	9.9e-05	0.000704	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	9.9e-05	0.000704	CbGpPWpGaD
Amisulpride—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	9.87e-05	0.000702	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	9.85e-05	0.000701	CbGpPWpGaD
Amisulpride—HTR2A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	9.84e-05	0.000699	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	9.79e-05	0.000696	CbGpPWpGaD
Amisulpride—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	9.71e-05	0.000691	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	9.68e-05	0.000688	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	9.65e-05	0.000687	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	9.63e-05	0.000685	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	9.62e-05	0.000684	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	9.59e-05	0.000682	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	9.52e-05	0.000677	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	9.5e-05	0.000676	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	9.35e-05	0.000665	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	9.32e-05	0.000663	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	9.22e-05	0.000656	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	9.17e-05	0.000652	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	9.16e-05	0.000651	CbGpPWpGaD
Amisulpride—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	9.05e-05	0.000644	CbGpPWpGaD
Amisulpride—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	9.05e-05	0.000643	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	9.05e-05	0.000643	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	9e-05	0.00064	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	8.98e-05	0.000639	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	8.95e-05	0.000637	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	8.95e-05	0.000636	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	8.85e-05	0.000629	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	8.77e-05	0.000623	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	8.71e-05	0.00062	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	8.62e-05	0.000613	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	8.57e-05	0.00061	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	8.56e-05	0.000609	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	8.52e-05	0.000606	CbGpPWpGaD
Amisulpride—HTR7—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	8.48e-05	0.000603	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	8.46e-05	0.000601	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	8.43e-05	0.0006	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	8.43e-05	0.000599	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	8.43e-05	0.000599	CbGpPWpGaD
Amisulpride—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	8.42e-05	0.000599	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	8.42e-05	0.000599	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	8.33e-05	0.000592	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	8.32e-05	0.000592	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	8.3e-05	0.00059	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	8.16e-05	0.00058	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	7.88e-05	0.00056	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	7.84e-05	0.000558	CbGpPWpGaD
Amisulpride—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	7.75e-05	0.000551	CbGpPWpGaD
Amisulpride—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	7.75e-05	0.000551	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	7.37e-05	0.000524	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	7.33e-05	0.000521	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	7.32e-05	0.000521	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	7.25e-05	0.000516	CbGpPWpGaD
Amisulpride—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	7.21e-05	0.000513	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	7.02e-05	0.000499	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	6.9e-05	0.000491	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.87e-05	0.000489	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.85e-05	0.000487	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	6.76e-05	0.000481	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	6.74e-05	0.000479	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	6.73e-05	0.000479	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	6.69e-05	0.000476	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	6.65e-05	0.000473	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.64e-05	0.000472	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	6.53e-05	0.000464	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	6.52e-05	0.000464	CbGpPWpGaD
Amisulpride—HTR7—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	6.46e-05	0.000459	CbGpPWpGaD
Amisulpride—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	6.44e-05	0.000458	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	6.44e-05	0.000458	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	6.42e-05	0.000456	CbGpPWpGaD
Amisulpride—HTR7—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	6.4e-05	0.000455	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	6.4e-05	0.000455	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	6.37e-05	0.000453	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	6.34e-05	0.000451	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	6.27e-05	0.000446	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.24e-05	0.000444	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	6.23e-05	0.000443	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	6.15e-05	0.000438	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.14e-05	0.000437	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	6.08e-05	0.000432	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	5.95e-05	0.000423	CbGpPWpGaD
Amisulpride—HTR2A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.9e-05	0.00042	CbGpPWpGaD
Amisulpride—HTR2B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.9e-05	0.00042	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.85e-05	0.000416	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	5.81e-05	0.000413	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	5.78e-05	0.000411	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	5.76e-05	0.00041	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5.73e-05	0.000407	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	5.67e-05	0.000403	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	5.66e-05	0.000403	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	5.65e-05	0.000402	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.61e-05	0.000399	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	5.59e-05	0.000398	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	5.56e-05	0.000395	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	5.52e-05	0.000393	CbGpPWpGaD
Amisulpride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	5.52e-05	0.000392	CbGpPWpGaD
Amisulpride—DRD3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	5.49e-05	0.000391	CbGpPWpGaD
Amisulpride—DRD3—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	5.45e-05	0.000387	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	5.44e-05	0.000387	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	5.44e-05	0.000387	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	5.4e-05	0.000384	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	5.31e-05	0.000378	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	5.29e-05	0.000376	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	5.27e-05	0.000374	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	5.23e-05	0.000372	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	5.21e-05	0.000371	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	5.18e-05	0.000368	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	5.18e-05	0.000368	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	5.14e-05	0.000366	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	5.11e-05	0.000364	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	5.08e-05	0.000361	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	5.08e-05	0.000361	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	5.06e-05	0.00036	CbGpPWpGaD
Amisulpride—HTR2A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	5.02e-05	0.000357	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.94e-05	0.000351	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.94e-05	0.000351	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.92e-05	0.00035	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.82e-05	0.000343	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.82e-05	0.000343	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	4.78e-05	0.00034	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.76e-05	0.000339	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.76e-05	0.000339	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.76e-05	0.000338	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.73e-05	0.000337	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.73e-05	0.000336	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.7e-05	0.000334	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.69e-05	0.000333	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.64e-05	0.00033	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.59e-05	0.000327	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	4.43e-05	0.000315	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.38e-05	0.000312	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	4.37e-05	0.000311	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.33e-05	0.000308	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.32e-05	0.000308	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	4.32e-05	0.000307	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.31e-05	0.000307	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.26e-05	0.000303	CbGpPWpGaD
Amisulpride—DRD2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.2e-05	0.000299	CbGpPWpGaD
Amisulpride—DRD2—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	4.17e-05	0.000296	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.16e-05	0.000296	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.1e-05	0.000291	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	4.02e-05	0.000286	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.93e-05	0.000279	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.87e-05	0.000275	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.81e-05	0.000271	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.78e-05	0.000269	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.76e-05	0.000268	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.75e-05	0.000267	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.72e-05	0.000265	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.7e-05	0.000263	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.69e-05	0.000262	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.69e-05	0.000262	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.69e-05	0.000262	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.65e-05	0.00026	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.64e-05	0.000259	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.63e-05	0.000258	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.63e-05	0.000258	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.62e-05	0.000257	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.59e-05	0.000255	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.58e-05	0.000255	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.56e-05	0.000253	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.52e-05	0.00025	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.46e-05	0.000246	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.43e-05	0.000244	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.41e-05	0.000242	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.35e-05	0.000238	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.35e-05	0.000238	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	3.34e-05	0.000238	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.34e-05	0.000237	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.34e-05	0.000237	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.31e-05	0.000236	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.31e-05	0.000235	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.29e-05	0.000234	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.25e-05	0.000231	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.19e-05	0.000227	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.14e-05	0.000223	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	3.1e-05	0.000221	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.09e-05	0.00022	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.04e-05	0.000216	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.03e-05	0.000215	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.03e-05	0.000215	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3e-05	0.000213	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.92e-05	0.000208	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.92e-05	0.000207	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.83e-05	0.000201	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.82e-05	0.0002	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.8e-05	0.000199	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.78e-05	0.000197	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.74e-05	0.000195	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.71e-05	0.000193	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.58e-05	0.000184	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.56e-05	0.000182	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.55e-05	0.000182	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.55e-05	0.000181	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.51e-05	0.000179	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.38e-05	0.000169	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.38e-05	0.000169	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.23e-05	0.000159	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.2e-05	0.000156	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.16e-05	0.000153	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.08e-05	0.000148	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.04e-05	0.000145	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.01e-05	0.000143	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.98e-05	0.000141	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.98e-05	0.000141	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.96e-05	0.000139	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.95e-05	0.000139	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.95e-05	0.000138	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.92e-05	0.000137	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.79e-05	0.000127	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.79e-05	0.000127	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.67e-05	0.000118	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.27e-05	9.06e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.04e-05	7.38e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	9.48e-06	6.74e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.82e-06	6.27e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.75e-06	4.8e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.64e-06	4.72e-05	CbGpPWpGaD
